FDA Inspection
Bausch Health Americas, Inc.Bausch Health Americas, Inc. – FDA Inspection, Apr 12, 2024
Record Details
This FDA Inspection record concerns Bausch Health Americas, Inc., with an inspection on April 12, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 528dd5c4-6070-4f28-8b4a-599e6fb40d7e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1236184
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Bausch Health Americas, Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| October 26, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 28, 2013 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 23, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 10, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 4, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Bausch Health Americas, Inc.
- FDA Inspection 946326 - 2015-10-26
- FDA Inspection 822504 - 2013-02-28
- FDA Inspection 829201 - 2013-01-23
- FDA Inspection 768467 - 2012-02-10
- FDA Inspection 696210 - 2010-11-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.